Thomas Pearson, M.D., MPH, Ph.D.

Discipline: Community and Preventive Medicine
Focus:
Email: thomas_pearson@urmc.rochester.edu

Biography

Dr. Pearson has several areas of research interests, all in the field of Preventive Cardiology. First, he has been interested in developing guidelines in Preventive Cardiology, examining the extent to which they are implemented, and identifying barriers to their implementation. He has been a writer of American Heart Association guidelines for the primary and secondary prevention of heart disease and stroke. He has been the Principal Investigator for the L-TAP and ACCEPT studies, examining the extent to which guidelines are carried out.

Second, Dr. Pearson has carried out clinical trials of dietary and drug interventions in lipid disorders. He has served on the Steering Committees or Data Safety and Monitoring Boards for VA-HIT, PROSPER, COURAGE, MADIT-II, and other multicenter trials. He has been a participant in randomized trials of new therapeutic agents. His particular interests have been in HDL metabolism and the role of lipoprotein (a) in atherogenesis.

Third, Dr. Pearson was one of the first to identify the spread of the coronary disease epidemic to developing countries. He has an interest in international trends in cardiovascular disease and stroke. He is a founding member of the World Heart Forum for Cardiovascular Disease Prevention and has served on international projects for the World Bank, World Heart Federation, and the International Heart Health Network. He is a coauthor of the Singapore and Osaka Declarations for Heart Health.